Research Open Terminal →

← Unusual insider activity · Company hub

BMY Bristol-Myers Squibb Co.

Insider figures are trailing 90 days, open-market Form 4 only. Institutional figures are the latest reported quarter. These windows are not simultaneous.

-$437K net selling - trailing 90 days

0 buyers - 2 unique sellers

Historical context: most recent complete month (2026-08) is the 48th percentile of this ticker's monthly net P/S flow over 23 complete months (limited history). Lower percentiles are more selling; higher are more buying.

6 accumulating - 7 trimming - 1 unchanged

14 comparable institutions - Q2 2026

open-market Form 4 only - grants, exercises, tax withholding excluded. ~ derived from SEC-reported shares x price.

Insider net $ (monthly)open-market Form 4 only - grants, exercises, tax withholding excluded$5.0M$2.5M$0-$2.5M-$5.0M2024-10 $02024-11 $61K2024-12 $02025-01 $02025-02 $210K2025-03 $02025-04 $202K2025-05 -$4K2025-06 $02025-07 $02025-08 -$17K2025-09 -$2.7M2025-10 $02025-11 $02025-12 $02026-01 $02026-02 $02026-03 $02026-04 -$1.9M2026-05 $02026-06 $02026-07 $02026-08 -$34K2026-09 -$403KInstitutional shares (majority-gated quarters)1.0B500.0M02025-Q4 661.4M sh2026-Q1 482.3M sh2026-Q2 470.0M shOct 24Dec 24Feb 25Apr 25Jun 25Aug 25Oct 25Dec 25Feb 26Apr 26Jun 26Aug 26Q4 2025Q1 2026Q2 2026~ derived from SEC-reported shares x price. Hatched: excluded (implausible price) or unpriced.

Who is responsible

Insider Role Net activity Rows
Massacesi Cristian EVP,Chief Med Offr,Head of Dev -~$0.4M 1
Holzer Phil M SVP and Controller -~$34K 1

Transactions

Date Insider Role Type Shares Price Value
9/9/2026 Massacesi Cristian EVP,Chief Med Offr,Head of Dev S -6249 64.57 ~$0.4M
8/25/2026 Holzer Phil M SVP and Controller S -500 67.5 ~$34K
4/1/2026 Elkins David V EVP, Chief Financial Officer 2 reported sale rows 30000 ~$1.9M
9/2/2025 Elkins David V EVP, Chief Financial Officer S -56000 47.33 ~$2.7M
8/2/2025 Short Bartie Wendy EVP, Corporate Affairs S -378 44.23 ~$17K
5/9/2025 Hickey Benjamin President, RayzeBio Org. S -97.391 38.01 ~$4K
4/25/2025 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. P 4250 47.58 ~$0.2M
2/20/2025 BOERNER CHRISTOPHER S. Chief Executive Officer P 2000 55.048 ~$0.1M
2/14/2025 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. P 1823.486 54.84 ~$100K
11/4/2024 Holzer Phil M SVP and Controller S -700 55.615 ~$39K
11/1/2024 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. P 1830 54.675 ~$0.1M